This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Resorcinol monoacetate
- DrugBank Accession Number
- DB15480
- Background
Not Available
- Type
- Small Molecule
- Groups
- Approved, Experimental
- Structure
Structure for Resorcinol monoacetate (DB15480)
- Weight
- Average: 152.149
Monoisotopic: 152.047344118 - Chemical Formula
- C8H8O3
- Synonyms
- Resorcinol acetate
- Resorcinol monoacetate
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- International/Other Brands
- Euresol
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Thomas Formula No 28 Resorcinol monoacetate (3.53 %) + Benzyl alcohol (.4386 %) + Salicylic acid (.4386 %) + Urea (1.77 %) Liquid Topical Thomas Hair And Scalp Specialists 1974-12-31 1997-01-08 Canada 
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- YL6O37RD1S
- CAS number
- 102-29-4
- InChI Key
- ZZPKZRHERLGEKA-UHFFFAOYSA-N
- InChI
- InChI=1S/C8H8O3/c1-6(9)11-8-4-2-3-7(10)5-8/h2-5,10H,1H3
- IUPAC Name
- 3-hydroxyphenyl acetate
- SMILES
- CC(=O)OC1=CC(O)=CC=C1
References
- General References
- Not Available
- External Links
- KEGG Compound
- C12064
- ChemSpider
- 4879
- 2106739
- ChEBI
- 29672
- ChEMBL
- CHEMBL1593874
- ZINC
- ZINC000000002029
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Liquid Topical - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 3.34 mg/mL ALOGPS logP 1.78 ALOGPS logP 1.28 Chemaxon logS -1.7 ALOGPS pKa (Strongest Acidic) 9.03 Chemaxon pKa (Strongest Basic) -6 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 46.53 Å2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 39.17 m3·mol-1 Chemaxon Polarizability 15.04 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-03di-3900000000-5b277810be5ef5ae77db Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-0pb9-0900000000-c4e7a598e64a93ec1af3 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-03e9-9700000000-9f0833ef3d1e9881aa39 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-0a4i-7900000000-f2262667f4cbaebc1111 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-000x-9000000000-77233feec0b28b2e4750 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-00kf-9100000000-7d856ab3d1d8e872bcb7 Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 135.5435102 predictedDarkChem Lite v0.1.0 [M-H]- 124.724846 predictedDeepCCS 1.0 (2019) [M+H]+ 136.0259102 predictedDarkChem Lite v0.1.0 [M+H]+ 128.55287 predictedDeepCCS 1.0 (2019) [M+Na]+ 135.6050102 predictedDarkChem Lite v0.1.0 [M+Na]+ 137.84267 predictedDeepCCS 1.0 (2019)
Drug created at August 30, 2019 15:47 / Updated at February 21, 2021 18:55